To view the PDF file, sign up for a MySharenet subscription.

GOLD FIELDS LIMITED - Dealing in securities

Release Date: 27/02/2024 12:34
Code(s): GFI     PDF:  
Wrap Text
Dealing in securities

Gold Fields Limited
Reg. No. 1968/004880/06)
(Incorporated in the Republic of South Africa)
JSE, NYSE, DIFX Share Code: GFI
ISIN Code:ZAE000018123
("Gold Fields" or the "Company")

DEALING IN SECURITIES

In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of
JSE Limited ("the Listings Requirements") the Company hereby advises that
directors and prescribed Officers of Gold Fields, and directors of major
subsidiaries of the Company took ownership of their vested Performance Shares
which were awarded in terms of the Gold Fields 2012 Share Plan ("Scheme") as
amended.

Accordingly, the following trades are announced:

Name of Director, Prescribed Officer,   PA Schmidt
Director of Major subsidiary
Nature of transaction                   On market sale of shares in terms of
                                        the above Scheme
Class of Security                       Ordinary shares
Nature of interest                      Direct and Beneficial
Transaction Date                        22/02/2024
Number of Shares traded                 177,189
Number of Shares retained               0
Market Price per share                  R230.0593
Total Value                             R40,763,977.31
Name of Director, Prescribed Officer,   KM Carter
Director of Major subsidiary
Nature of transaction                   Deferral of Performance Shares to
                                        Restricted Shares towards Minimum
                                        Shareholding Requirement
Class of Security                       Ordinary shares
Nature of interest                      Direct and Beneficial
Transaction Date                        22/02/2024
Number of Shares traded                 0
Number of Shares retained               12,924
Market Price per share                  R230.0593
Total Value                             R2,973,286.39
Name of Director, Prescribed Officer,   G Lotz
Director of Major subsidiary
Nature of transaction                   On market sale of shares in terms of
                                        the above Scheme
Class of Security                       Ordinary shares
Nature of interest                      Direct and Beneficial
Transaction Date                        22/02/2024
Number of Shares traded                 15,362
Number of Shares retained               0
Market Price per share                  R230.0593
Total Value                             R3,534,170.97
Name of Director, Prescribed Officer,   S Mathews
Director of Major subsidiary
Nature of transaction                   On market sale of shares in terms of
                                        the above Scheme
Class of Security                       Ordinary shares
Nature of interest                      Direct and Beneficial
Transaction Date                        22/02/2024
Number of Shares traded                 129,433
Number of Shares retained                0
Market Price per share                   R230.0593
Total Value                              R29,777,265.38
Name of Director, Prescribed Officer,    BL Mokoatle
Director of Major subsidiary
Nature of transaction                    On market sale of shares in terms of
                                         the above Scheme
Class of Security                        Ordinary shares
Nature of interest                       Direct and Beneficial
Transaction Date                         22/02/2024
Number of Shares traded                  9,193
Number of Shares retained                10,577
Market Price per share                   R230.0593
Total Value                              R4,548,272.36
Name of Director, Prescribed Officer,    JK Mortoti
Director of Major subsidiary
Nature of transaction                    On market sale of shares in terms of
                                         the above Scheme
Class of Security                        Ordinary shares
Nature of interest                       Direct and Beneficial
Transaction Date                         22/02/2024
Number of Shares traded                  14,574
Number of Shares retained                0
Market Price per share                   R230.0593
Total Value                              R3,352,884.24
Name of Director, Prescribed Officer,    M Preece
Director of Major subsidiary
Nature of transaction                    On market sale of shares in terms of
                                         the above Scheme
Class of Security                        Ordinary shares
Nature of interest                       Direct and Beneficial
Transaction Date                         22/02/2024
Number of Shares traded                  61,446
Number of Shares retained                70,696
Market Price per share                   R230.0593
Total Value                              R30,400,496.02
Name of Director, Prescribed Officer,    L Rivera
Director of Major subsidiary
Nature of transaction                    On market sale of shares in terms of
                                         the above Scheme
Class of Security                        Ordinary shares
Nature of interest                       Direct and Beneficial
Transaction Date                         22/02/2024
Number of Shares traded                  135,348
Number of Shares retained                0
Market Price per share                   R230.0593
Total Value                              R31,138,066.14

In terms of paragraph 3.66 of the Listings requirements the necessary clearance
to deal in the above securities has been obtained.

27 February 2023
Sponsor:
J.P. Morgan Equities South Africa (Pty) Ltd

Date: 27-02-2024 12:34:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story